Work

PT1.01.03 IMPRINT-Lung: Single-Arm, Multi-Center Phase II Trial of Immunotherapy With Pembrolizumab for Interception of High-Risk Lung Nodules

Year: 2025

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2025.09.1108

Authors: J.J. Zhang, M. Godoy, V. Velcheti, D. Sterman, A. Tam, R. Rajaram, H. Tran, R. Keith, S. Heeke, H. Chen, B. Carter, M. Antonoff, E. Ostrin, X. Le, C. Gay, M.V. Negrao, J.V. Pozadzides, S.H. Lin, L. Byers, N. Vokes, T. Cascone, D.L. Gibbons, B. Zhang, H. Araujo, C. Lu, G. Blumenschein, D. Rice, G.L. Walsh, J. Chang, Z. Liao, W.L. Hofstetter, R. Mehran, A. Vaporciyan, I. Wistuba, J. Wu, J.J. Lee, J.V. Heymach

Institutions: The University of Texas MD Anderson Cancer Center, New York University, University of Colorado Denver

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415519144

FWCI: 0.591

Cites:

Cited by: 1

Related to: